Reproducible Community Dynamics of the Gastrointestinal Microbiota following Antibiotic Perturbation

ABSTRACT Shifts in microbial communities are implicated in the pathogenesis of a number of gastrointestinal diseases, but we have limited understanding of the mechanisms that lead to altered community structures. One difficulty with studying these mechanisms in human subjects is the inherent baseline variability of the microbiota in different individuals. In an effort to overcome this baseline variability, we employed a mouse model to control the host genotype, diet, and other possible influences on the microbiota. This allowed us to determine whether the indigenous microbiota in such mice had a stable baseline community structure and whether this community exhibited a consistent response following antibiotic administration. We employed a tag-sequencing strategy targeting the V6 hypervariable region of the bacterial small-subunit (16S) rRNA combined with massively parallel sequencing to determine the community structure of the gut microbiota. Inbred mice in a controlled environment harbored a reproducible baseline community that was significantly impacted by antibiotic administration. The ability of the gut microbial community to recover to baseline following the cessation of antibiotic administration differed according to the antibiotic regimen administered. Severe antibiotic pressure resulted in reproducible, long-lasting alterations in the gut microbial community, including a decrease in overall diversity. The finding of stereotypic responses of the indigenous microbiota to ecologic stress suggests that a better understanding of the factors that govern community structure could lead to strategies for the intentional manipulation of this ecosystem so as to preserve or restore a healthy microbiota.

[1]  Susan M. Huse,et al.  Exploring Microbial Diversity and Taxonomy Using SSU rRNA Hypervariable Tag Sequencing , 2008, PLoS genetics.

[2]  D. Broide Allergic Disease , 2020, Berkowitz’s Pediatrics Instructor’s Guide.

[3]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[4]  J. Bartlett,et al.  Historical perspectives on studies of Clostridium difficile and C. difficile infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  E. Vollaard,et al.  Colonization resistance , 1994, Antimicrobial Agents and Chemotherapy.

[6]  E. Zoetendal,et al.  Temperature Gradient Gel Electrophoresis Analysis of 16S rRNA from Human Fecal Samples Reveals Stable and Host-Specific Communities of Active Bacteria , 1998, Applied and Environmental Microbiology.

[7]  J. Bakken,et al.  Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  S. Conway,et al.  Bacterial modulation of mucosal innate immunity. , 2005, Molecular immunology.

[9]  Robert C. Edgar,et al.  MUSCLE: multiple sequence alignment with high accuracy and high throughput. , 2004, Nucleic acids research.

[10]  K. Madsen,et al.  Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. , 2000, Gastroenterology.

[11]  A. Solow,et al.  Measuring biological diversity , 2006, Environmental and Ecological Statistics.

[12]  K. Wilson,et al.  Human colonic biota studied by ribosomal DNA sequence analysis , 1996, Applied and environmental microbiology.

[13]  M. Membrez,et al.  Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  K. Wilson The microecology of Clostridium difficile. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  Susan M. Huse,et al.  Accuracy and quality of massively parallel DNA pyrosequencing , 2007, Genome Biology.

[16]  S. Allison,et al.  Resistance, resilience, and redundancy in microbial communities , 2008, Proceedings of the National Academy of Sciences.

[17]  Jeffrey D Goldsmith,et al.  A mouse model of Clostridium difficile-associated disease. , 2008, Gastroenterology.

[18]  T Midtvedt,et al.  A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  W. Moore,et al.  Human fecal flora: variation in bacterial composition within individuals and a possible effect of emotional stress , 1976, Applied and environmental microbiology.

[20]  F. Shanahan,et al.  Culture-Independent Analyses of Temporal Variation of the Dominant Fecal Microbiota and Targeted Bacterial Subgroups in Crohn's Disease , 2006, Journal of Clinical Microbiology.

[21]  G. Huffnagle,et al.  The ‘microflora hypothesis’ of allergic diseases , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[22]  Courtney J. Robinson,et al.  Rules of engagement: interspecies interactions that regulate microbial communities. , 2008, Annual review of microbiology.

[23]  N. Pace,et al.  Gastrointestinal microbiology enters the metagenomics era , 2008, Current opinion in gastroenterology.

[24]  Ruslan Medzhitov,et al.  Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.

[25]  D. Savage Microbial ecology of the gastrointestinal tract. , 1977, Annual review of microbiology.

[26]  R. Flavell,et al.  An Antibiotic-Responsive Mouse Model of Fulminant Ulcerative Colitis , 2008, PLoS medicine.

[27]  Ronald P. DeMatteo,et al.  Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits , 2008, Nature.

[28]  W. Walker Mechanisms of action of probiotics. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  Robert K. Colwell,et al.  Quantifying biodiversity: procedures and pitfalls in the measurement and comparison of species richness , 2001 .

[30]  P. Sansonetti,et al.  Debugging how bacteria manipulate the immune response. , 2007, Immunity.

[31]  A. Chao Nonparametric estimation of the number of classes in a population , 1984 .

[32]  P. Turnbaugh,et al.  Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.

[33]  J. Gordon,et al.  A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Freter,et al.  In vivo and in vitro antagonism of intestinal bacteria against Shigella flexneri. I. Correlation between various tests. , 1962, The Journal of infectious diseases.

[35]  R. Ley,et al.  Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine , 2006, Cell.

[36]  K. Verbeke,et al.  Molecular Monitoring of the Fecal Microbiota of Healthy Human Subjects during Administration of Lactulose and Saccharomyces boulardii , 2006, Applied and Environmental Microbiology.

[37]  E. Mylonakis,et al.  Clostridium difficile--Associated diarrhea: A review. , 2001, Archives of internal medicine.

[38]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[39]  R. Freter In vivo and in vitro antagonism of intestinal bacteria against Shigellaflexneri. II. The inhibitory mechanism. , 1962, The Journal of infectious diseases.

[40]  N. Pace,et al.  Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. , 2008, Cell host & microbe.

[41]  R. Knight,et al.  Evolution of Mammals and Their Gut Microbes , 2008, Science.

[42]  R Balfour Sartor,et al.  Microbial influences in inflammatory bowel diseases. , 2008, Gastroenterology.

[43]  J. Handelsman,et al.  Introducing DOTUR, a Computer Program for Defining Operational Taxonomic Units and Estimating Species Richness , 2005, Applied and Environmental Microbiology.

[44]  R. Satokari,et al.  Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria. , 2006, Journal of medical microbiology.

[45]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[46]  Neil Hunter,et al.  Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. , 2002, Microbiology.

[47]  S. Maroo,et al.  Recurrent clostridium difficile. , 2006, Gastroenterology.

[48]  D. Relman,et al.  Assembly of the human intestinal microbiota. , 2006, Trends in ecology & evolution.

[49]  J. Rask-Madsen,et al.  BACTERIOTHERAPY FOR CHRONIC RELAPSING CLOSTRIDIUM DIFFICILE DIARRHOEA IN SIX PATIENTS , 1989, The Lancet.

[50]  B. Finlay,et al.  Antibiotic-Induced Perturbations of the Intestinal Microbiota Alter Host Susceptibility to Enteric Infection , 2008, Infection and Immunity.

[51]  L. Beaugerie,et al.  Effect of Antibiotic Therapy on Human Fecal Microbiota and the Relation to the Development of Clostridium difficile , 2008, Microbial Ecology.

[52]  J. Jansson,et al.  Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes. , 2006, The Journal of antimicrobial chemotherapy.

[53]  Susan M. Huse,et al.  Microbial diversity in the deep sea and the underexplored “rare biosphere” , 2006, Proceedings of the National Academy of Sciences.

[54]  W. Walker,et al.  Probiotics and chronic disease. , 2006, Journal of clinical gastroenterology.

[55]  N. Pace A molecular view of microbial diversity and the biosphere. , 1997, Science.

[56]  R Balfour Sartor,et al.  Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. , 2008, Cell host & microbe.

[57]  F. Bäckhed,et al.  Host-Bacterial Mutualism in the Human Intestine , 2005, Science.

[58]  Les Dethlefsen,et al.  The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing , 2008, PLoS biology.

[59]  G. Huffnagle,et al.  The "Microflora Hypothesis" of allergic disease. , 2008, Advances in experimental medicine and biology.

[60]  Susan M. Huse,et al.  Microbial Population Structures in the Deep Marine Biosphere , 2007, Science.

[61]  A. Magurran,et al.  Measuring Biological Diversity , 2004 .

[62]  W. Siegert,et al.  Quantification of human cells in NOD/SCID mice by duplex real-time polymerase-chain reaction. , 2001, Haematologica.

[63]  D. Antonopoulos,et al.  Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. , 2008, The Journal of infectious diseases.

[64]  M. Sanders Probiotics: definition, sources, selection, and uses. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.